Dr. Alexis Da Silva, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,778 | 592 | 99.2% |
| Education | $85.21 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,566 | 107 | $0 (2024) |
| Novo Nordisk Inc | $1,401 | 105 | $0 (2024) |
| Amgen Inc. | $1,056 | 43 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $877.76 | 43 | $0 (2024) |
| Mannkind Corporation | $659.99 | 41 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $479.78 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $467.03 | 18 | $0 (2024) |
| ABBVIE INC. | $400.78 | 31 | $0 (2024) |
| Dexcom, Inc. | $381.93 | 14 | $0 (2024) |
| Insulet Corporation | $259.53 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,733 | 128 | Lilly USA, LLC ($451.92) |
| 2023 | $2,697 | 158 | Lilly USA, LLC ($534.61) |
| 2022 | $2,562 | 145 | Amgen Inc. ($395.02) |
| 2021 | $1,898 | 118 | Novo Nordisk Inc ($390.47) |
| 2020 | $800.44 | 46 | SANOFI-AVENTIS U.S. LLC ($145.44) |
| 2019 | $93.68 | 1 | Novo Nordisk Inc ($93.68) |
| 2018 | $79.43 | 1 | Medtronic MiniMed, Inc. ($79.43) |
All Payment Transactions
597 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Automated insulin delivery system | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Automated insulin delivery system | ||||||
| 11/06/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/05/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Endocrinology | ||||||
| 10/20/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $100.65 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: OSTEOPOROSIS | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Endocrinology | ||||||
| 09/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,693 | 8,573 | $615,190 | $239,559 |
| 2022 | 41 | 5,540 | 9,511 | $428,869 | $171,870 |
| 2021 | 36 | 3,231 | 5,882 | $262,940 | $106,826 |
| 2020 | 30 | 1,194 | 1,386 | $65,517 | $26,443 |
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 458 | 925 | $189,331 | $87,183 | 46.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 57 | 404 | $40,400 | $19,051 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $45,431 | $17,270 | 38.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 139 | 154 | $34,531 | $13,227 | 38.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 395 | 719 | $34,598 | $11,802 | 34.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 61 | 281 | $33,720 | $10,531 | 31.2% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 285 | 460 | $20,718 | $7,587 | 36.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 395 | 729 | $43,740 | $7,515 | 17.2% |
| 82985 | Glycated protein level | Office | 2023 | 231 | 423 | $18,265 | $6,946 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 427 | 813 | $8,130 | $6,821 | 83.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 163 | 228 | $18,240 | $6,587 | 36.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 282 | 492 | $18,883 | $6,455 | 34.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 385 | 697 | $20,910 | $6,128 | 29.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 37 | 158 | $17,380 | $5,985 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 53 | $7,214 | $3,614 | 50.1% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 259 | 539 | $3,234 | $2,658 | 82.2% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 23 | 24 | $7,200 | $2,570 | 35.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 53 | 91 | $7,850 | $2,516 | 32.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 42 | 56 | $6,621 | $2,227 | 33.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 209 | 354 | $6,018 | $2,163 | 35.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 209 | 354 | $5,310 | $1,798 | 33.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 40 | $3,200 | $1,407 | 44.0% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 15 | 30 | $3,000 | $1,243 | 41.4% |
| 84445 | Thyroid stimulating immune globulins (thyroid related protein) level | Office | 2023 | 22 | 22 | $2,640 | $1,096 | 41.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 67 | 77 | $2,141 | $733.04 | 34.2% |
About Dr. Alexis Da Silva, MD
Dr. Alexis Da Silva, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1568857530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Da Silva, MD has received a total of $10,863 in payments from pharmaceutical and medical device companies, with $2,733 received in 2024. These payments were reported across 597 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,778).
As a Medicare-enrolled provider, Da Silva has provided services to 14,658 Medicare beneficiaries, totaling 25,352 services with total Medicare billing of $544,697. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location West Palm Beach, FL
- Active Since 04/06/2015
- Last Updated 10/29/2020
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1568857530
Products in Payments
- MOUNJARO (Drug) $682.66
- AFREZZA (Drug) $659.99
- Ozempic (Drug) $627.29
- EVENITY (Biological) $517.74
- JARDIANCE (Drug) $483.21
- Repatha (Biological) $479.27
- SOLIQUA 100/33 (Biological) $471.63
- Kerendia (Drug) $467.03
- SYNTHROID (Drug) $400.78
- GVOKE PFS (Drug) $299.40
- Dexcom G6 Transmitter (Medical Supply) $281.28
- BAQSIMI (Drug) $261.48
- Omnipod (Device) $259.53
- TRULICITY (Drug) $244.94
- TZIELD (Biological) $231.45
- Rybelsus (Drug) $228.39
- UNITHROID (Drug) $222.77
- iLet Bionic Pancreas (Device) $204.27
- Vascepa (Drug) $199.04
- t:slim X2 Insulin Pump with Control-IQ (Device) $198.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in West Palm Beach
Barry Horowitz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $991,672
William Kaye, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $541,803
Dr. Geetanjali Kale, Mbbs, MBBS
Endocrinology, Diabetes & Metabolism — Payments: $19,378
Dr. Sharon Miller, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $15,650
Kort Knudson, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,488
Morolake Amole, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $8,876